21 November 2025
Latham & Watkins Advises on Keros Therapeutics, Inc.’s US$194.4 Million Tender Offer
Capital Markets & IPO Completed
Advising firms
Deal team
6 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Greg Rodgers Lead | Latham & Watkins LLP | Partner | Capital Markets | Not stated |
| Nathan Ajiashvili Lead | Latham & Watkins LLP | Partner | Capital Markets | Not stated |
| Brice Stewart | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
| Alondra Tlatelpa | Latham & Watkins LLP | Not stated | Capital Markets | Not stated |
| Eric Cho | Latham & Watkins LLP | Partner | tax | Not stated |
| Daniel Mousseri | Latham & Watkins LLP | Not stated | tax | Not stated |
3 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 194m (US$194.4 million)
- What the figure measures
- Total transaction value
- Client
- Keros Therapeutics, Inc.Issuer
- Counterparties
- Not stated